January 28, 2025
Interview with Dr. Megan Smithmyer: Type 1 Diabetes Biorepository (BRIDge Study)
Read Article
October 23, 2024
Innovation Fund Spotlight: Single-Cell CRISPR Screening To Explore Genetics and Autoimmune Diseases
Together, Jessica Hamerman, PhD, and John Ray, PhD, are exploring the genetic roots of autoimmune disease using single-cell CRISPR screening.
October 23, 2024
Innovation Fund Spotlight: Lab-Grown Beta Cells Meet State-Of-The-Art Imaging To Answer New Questions About Type 1 Diabetes
BRI investigators Eddie James, PhD, and Caroline Stefani, PhD, are teaming up to take a unique approach to type 1 diabetes research.
October 4, 2024
Kazushige Ninomiya, PhD: Finding New Answers in Cancer
Read about the questions Dr. Ninomiya will ask about one of the most devastating forms of cancer.
October 4, 2024
Kurt Griffin, MD, PhD: Exploring New Ways to Prevent Type 1 Diabetes
Learn about exciting new type 1 diabetes research Dr. Griffin is taking on at BRI.
October 4, 2024
Allyson Byrd, PhD: Can Gut Bacteria Help Treat Cancer?
Why does a medicine work for one person, but not another with the same disease? Dr. Byrd is seeking answers in a place that some people might find surprising.
October 2, 2024
Out-Of-The-Box Idea Yields Important Answers About Lupus
Hayley Waterman, PhD, asked an outside-the-box research question about lupus — and found groundbreaking answers.
October 2, 2024
Advances in T1D Prediction: An Algorithm To Help Define When a Person May Develop T1D
Learn how a team led by Carla Greenbaum, MD, is using “fancy math” to better understand not only if a person will develop T1D, but when.
September 24, 2024
Second Annual BRI T1D Family Day
June 1, 2024, marked the second annual Benaroya Research Institute T1D Family Day.
September 24, 2024
Working Toward Cures
Did you know that if risk screening results show you are in the early stages of T1D, you may be eligible to participate in a type 1 diabetes prevention study?
July 3, 2024
Investigating a Little-Understood Cell in MS
Find out how Estelle Bettelli, PhD, and her team are examining guardian cells that may play a big role in MS.
